The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Immunomodulatory Nanosystems
Open accessAbstract
Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome many obstacles facing the treatment method, such as inadequate immune stimulation, off‐target side effects, and bioactivity loss of immune agents during circulation. In recent years, researchers have continuously developed nanomaterials with new structures, properties, and functions. This Review provides the most recent advances of nanotechnology for immunostimulation and immunosuppression. In cancer immunotherapy, nanosystems play an essential role in immune cell activation and tumor microenvironment modulation, as well as combination with other antitumor approaches. In infectious diseases, many encouraging outcomes from using nanomaterial vaccines against viral and bacterial infections have been reported. In addition, nanoparticles also potentiate the effects of immunosuppressive immune cells for the treatment of inflammatory and autoimmune diseases. Finally, the challenges and prospects of applying nanotechnology to modulate immunotherapy are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Rosenberg, J. E., Hoffman-Censits, J., Powles, T., van der Heijden, M. S., Balar, A. V., Necchi, A., Dawson, N., O'Donnell, P. H., Balmanoukian, A., Loriot, Y., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00561-4 · Cited by 3,669
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
The challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
Ultrasmall Reduced Graphene Oxide with High Near-Infrared Absorbance for Photothermal Therapy
Robinson, J. T., Tabakman, S. M., Liang, Y., Wang, H., Sanchez Casalongue, H., Vinh, D., & Dai, H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2010175 · Cited by 2,099
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
Chen, Q., Xu, L., Liang, C., Wang, C., Peng, R., & Liu, Z. (2016) · Nature Communications · doi:10.1038/ncomms13193 · Cited by 1,596
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Zelenay, S., van der Veen, A. G., Böttcher, J. P., Snelgrove, K. J., Rogers, N., Acton, S. E., Chakravarty, P., Girotti, M. R., Marais, R., Quezada, S. A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.015 · Cited by 1,128
Rodell, C. B., Arlauckas, S. P., Cuccarese, M. F., Garris, C. S., Li, R., Ahmed, M. S., Kohler, R. H., Pittet, M. J., & Weissleder, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0236-8 · Cited by 1,099
Macrophage Polarization in Inflammatory Diseases
Liu, Y.-C., Zou, X.-B., Chai, Y.-F., & Yao, Y.-M. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8879 · Cited by 1,085
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Engineered T cells: the promise and challenges of cancer immunotherapy
Fesnak, A. D., June, C. H., & Levine, B. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.97 · Cited by 1,074
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Designer vaccine nanodiscs for personalized cancer immunotherapy
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017) · Nature Materials · doi:10.1038/nmat4822 · Cited by 1,056
Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0883 · Cited by 1,054
Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J.-M., Jack, R. S., Wunderlich, F. T., Brüning, J. C., Müller, W., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.018 · Cited by 980
Xue, J., Zhao, Z., Zhang, L., Xue, L., Shen, S., Wen, Y., Wei, Z., Wang, L., Kong, L., Sun, H., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.54 · Cited by 959
Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
Ellis, T. N., & Kuehn, M. J. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-09 · Cited by 955
Structure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Krummel, M. F., & Allison, J. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2533 · Cited by 932
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Khalil, D. N., Smith, E. L., Brentjens, R. J., & Wolchok, J. D. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.25 · Cited by 929
Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens
Finlay, B. B., & McFadden, G. (2006) · Cell · doi:10.1016/j.cell.2006.01.034 · Cited by 904
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Functionalized Gold Nanoparticles and Their Biomedical Applications
Tiwari, P. M., Vig, K., Dennis, V. A., & Singh, S. R. (2011) · Nanomaterials · doi:10.3390/nano1010031 · Cited by 840
Alternative Antimicrobial Approach: Nano-Antimicrobial Materials
Beyth, N., Houri-Haddad, Y., Domb, A., Khan, W., & Hazan, R. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/246012 · Cited by 837
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Emens, L. A., & Middleton, G. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0064 · Cited by 831
Kratz, M., Coats, B. R., Hisert, K. B., Hagman, D., Mutskov, V., Peris, E., Schoenfelt, K. Q., Kuzma, J. N., Larson, I., Billing, P. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.010 · Cited by 815
Nam, J., Son, S., Ochyl, L. J., Kuai, R., Schwendeman, A., & Moon, J. J. (2018) · Nature Communications · doi:10.1038/s41467-018-03473-9 · Cited by 808
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., van Endert, P., & Amigorena, S. (2003) · Nature · doi:10.1038/nature01911 · Cited by 753
A biomimetic nanosponge that absorbs pore-forming toxins
Hu, C.-M. J., Fang, R. H., Copp, J., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.54 · Cited by 751
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Min, Y., Roche, K. C., Tian, S., Eblan, M. J., McKinnon, K. P., Caster, J. M., Chai, S., Herring, L. E., Zhang, L., Zhang, T., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.113 · Cited by 701
Yang, R., Xu, J., Xu, L., Sun, X., Chen, Q., Zhao, Y., Peng, R., & Liu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09041 · Cited by 698
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.006 · Cited by 679
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Chen, Q., Chen, J., Yang, Z., Xu, J., Xu, L., Liang, C., Han, X., & Liu, Z. (2019) · Advanced Materials · doi:10.1002/adma.201802228 · Cited by 661
Stimuli-responsive bio-based polymeric systems and their applications
Gao, S., Tang, G., Hua, D., Xiong, R., Han, J., Jiang, S., Zhang, Q., & Huang, C. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb02491j · Cited by 605
Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A., & Sher, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051782 · Cited by 601
Advances in the development of influenza virus vaccines
Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 597
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M., & Röcken, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1961 · Cited by 594
Lipid nanoparticles enabling gene therapies: from concepts to clinical utility
Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592
Vankayala, R., & Hwang, K. C. (2018) · Advanced Materials · doi:10.1002/adma.201706320 · Cited by 557
Recent advances in the use of cell-penetrating peptides for medical and biological applications☆
Fonseca, S. B., Pereira, M. P., & Kelley, S. O. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.001 · Cited by 553
Development of TGF-β signalling inhibitors for cancer therapy
Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 549
Gujrati, V., Kim, S., Kim, S.-H., Min, J. J., Choy, H. E., Kim, S. C., & Jon, S. (2014) · ACS Nano · doi:10.1021/nn405724x · Cited by 543
Oh, E. J., Park, K., Kim, K. S., Kim, J., Yang, J.-A., Kong, J.-H., Lee, M. Y., Hoffman, A. S., & Hahn, S. K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.010 · Cited by 540
Butts, C., Socinski, M. A., Mitchell, P. L., Thatcher, N., Havel, L., Krzakowski, M., Nawrocki, S., Ciuleanu, T.-E., Bosquée, L., Trigo, J. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70510-2 · Cited by 538
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Cronstein, B. N. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.3 · Cited by 535
Guo, L., Yan, D. D., Yang, D., Li, Y., Wang, X., Zalewski, O., Yan, B., & Lu, W. (2014) · ACS Nano · doi:10.1021/nn5002112 · Cited by 532
Kester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
Expanding antigen-specific regulatory networks to treat autoimmunity
Clemente-Casares, X., Blanco, J., Ambalavanan, P., Yamanouchi, J., Singha, S., Fandos, C., Tsai, S., Wang, J., Garabatos, N., Izquierdo, C., et al. (2016) · Nature · doi:10.1038/nature16962 · Cited by 510
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
Gao, W., Fang, R. H., Thamphiwatana, S., Luk, B. T., Li, J., Angsantikul, P., Zhang, Q., Hu, C.-M. J., & Zhang, L. (2015) · Nano Letters · doi:10.1021/nl504798g · Cited by 509
Cosimi, A. B., Colvin, R. B., Burton, R. C., Rubin, R. H., Goldstein, G., Kung, P. C., Hansen, W. P., Delmonico, F. L., & Russell, P. S. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108063050603 · Cited by 505
WHITESIDE, T. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.008 · Cited by 487
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Holmgaard, R. B., Zamarin, D., Li, Y., Gasmi, B., Munn, D. H., Allison, J. P., Merghoub, T., & Wolchok, J. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.077 · Cited by 482
Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
Wiemann, B., & Starnes, C. O. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90023-x · Cited by 467
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Wang, H., & Mooney, D. J. (2018) · Nature Materials · doi:10.1038/s41563-018-0147-9 · Cited by 467
Choo, Y. W., Kang, M., Kim, H. Y., Han, J., Kang, S., Lee, J.-R., Jeong, G.-J., Kwon, S. P., Song, S. Y., Go, S., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02446 · Cited by 465
Neoantigen landscape dynamics during human melanoma–T cell interactions
Verdegaal, E. M. E., de Miranda, N. F. C. C., Visser, M., Harryvan, T., van Buuren, M. M., Andersen, R. S., Hadrup, S. R., van der Minne, C. E., Schotte, R., Spits, H., et al. (2016) · Nature · doi:10.1038/nature18945 · Cited by 461
Maus, M. V., Thomas, A. K., Leonard, D. G. B., Allman, D., Addya, K., Schlienger, K., Riley, J. L., & June, C. H. (2002) · Nature Biotechnology · doi:10.1038/nbt0202-143 · Cited by 454
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
Ghoreschi, K., Thomas, P., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R., Biedermann, T., Prinz, J., Mack, M., et al. (2003) · Nature Medicine · doi:10.1038/nm804 · Cited by 453
Feng, B., Zhou, F., Hou, B., Wang, D., Wang, T., Fu, Y., Ma, Y., Yu, H., & Li, Y. (2018) · Advanced Materials · doi:10.1002/adma.201803001 · Cited by 451
T cell‐targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Schmid, D., Park, C. G., Hartl, C. A., Subedi, N., Cartwright, A. N., Puerto, R. B., Zheng, Y., Maiarana, J., Freeman, G. J., Wucherpfennig, K. W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01830-8 · Cited by 449
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Maldonado, R. A., LaMothe, R. A., Ferrari, J. D., Zhang, A.-H., Rossi, R. J., Kolte, P. N., Griset, A. P., O’Neil, C., Altreuter, D. H., Browning, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408686111 · Cited by 441
Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Van Damme, J., & Mantovani, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.762 · Cited by 426
Harrigan, P. R., Hogg, R. S., Dong, W. W. Y., Yip, B., Wynhoven, B., Woodward, J., Brumme, C. J., Brumme, Z. L., Mo, T., Alexander, C. S., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427192 · Cited by 424
Sequentially Responsive Shell‐Stacked Nanoparticles for Deep Penetration into Solid Tumors
Chen, J., Ding, J., Wang, Y., Cheng, J., Ji, S., Zhuang, X., & Chen, X. (2017) · Advanced Materials · doi:10.1002/adma.201701170 · Cited by 420
Self-citationChahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., Sidik, S. M., Lourido, S., Langer, R., Bavari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600299113 · Cited by 414
Development of a novel endosomolytic diblock copolymer for siRNA delivery
Convertine, A. J., Benoit, D. S. W., Duvall, C. L., Hoffman, A. S., & Stayton, P. S. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.004 · Cited by 406
Holst, J., Martin, D., Arnold, R., Huergo, C. C., Oster, P., O’Hallahan, J., & Rosenqvist, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.071 · Cited by 405
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
Burgdorf, S., Schölz, C., Kautz, A., Tampé, R., & Kurts, C. (2008) · Nature Immunology · doi:10.1038/ni.1601 · Cited by 405
Lee, T. T., García, J. R., Paez, J. I., Singh, A., Phelps, E. A., Weis, S., Shafiq, Z., Shekaran, A., del Campo, A., & García, A. J. (2015) · Nature Materials · doi:10.1038/nmat4157 · Cited by 402
Yang, G., Xu, L., Xu, J., Zhang, R., Song, G., Chao, Y., Feng, L., Han, F., Dong, Z., Li, B., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00040 · Cited by 397
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392
Desreumaux, P., Foussat, A., Allez, M., Beaugerie, L., Hébuterne, X., Bouhnik, Y., Nachury, M., Brun, V., Bastian, H., Belmonte, N., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.116 · Cited by 384
Song, W., Shen, L., Wang, Y., Liu, Q., Goodwin, T. J., Li, J., Dorosheva, O., Liu, T., Liu, R., & Huang, L. (2018) · Nature Communications · doi:10.1038/s41467-018-04605-x · Cited by 375
Self-citationEfficient Nanovaccine Delivery in Cancer Immunotherapy
Zhu, G., Zhang, F., Ni, Q., Niu, G., & Chen, X. (2017) · ACS Nano · doi:10.1021/acsnano.7b00978 · Cited by 374
Self-citationCheng, L., Wang, Y., & Huang, L. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.02.007 · Cited by 364
Nanoparticle-detained toxins for safe and effective vaccination
Hu, C.-M. J., Fang, R. H., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.254 · Cited by 342
James, J. A., Gross, T., Scofield, R. H., & Harley, J. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.453 · Cited by 339
Bisikirska, B., Colgan, J., Luban, J., Bluestone, J. A., & Herold, K. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23961 · Cited by 339
Side effects and emotional distress during cancer chemotherapy
Love, R. R., Leventhal, H., Easterling, D. V., & Nerenz, D. R. (1989) · Cancer · doi:10.1002/1097-0142(19890201)63:3<604::aid-cncr2820630334>3.0.co;2-2 · Cited by 338
Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy
Ni, K., Lan, G., Veroneau, S. S., Duan, X., Song, Y., & Lin, W. (2018) · Nature Communications · doi:10.1038/s41467-018-06655-7 · Cited by 329
Cheng, K., Ding, Y., Zhao, Y., Ye, S., Zhao, X., Zhang, Y., Ji, T., Wu, H., Wang, B., Anderson, G. J., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01071 · Cited by 325
Song, W., Kuang, J., Li, C.-X., Zhang, M., Zheng, D., Zeng, X., Liu, C., & Zhang, X.-Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09112 · Cited by 314
Self-citationReversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
Tsai, S., Shameli, A., Yamanouchi, J., Clemente-Casares, X., Wang, J., Serra, P., Yang, Y., Medarova, Z., Moore, A., & Santamaria, P. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.015 · Cited by 309
Oelke, M., Maus, M. V., Didiano, D., June, C. H., Mackensen, A., & Schneck, J. P. (2003) · Nature Medicine · doi:10.1038/nm869 · Cited by 306
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
Tokatlian, T., Read, B. J., Jones, C. A., Kulp, D. W., Menis, S., Chang, J. Y. H., Steichen, J. M., Kumari, S., Allen, J. D., Dane, E. L., et al. (2019) · Science · doi:10.1126/science.aat9120 · Cited by 305
Müller-Hermelink, N., Braumüller, H., Pichler, B., Wieder, T., Mailhammer, R., Schaak, K., Ghoreschi, K., Yazdi, A., Haubner, R., Sander, C. A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.001 · Cited by 302
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
Chen, D. J., Osterrieder, N., Metzger, S. M., Buckles, E., Doody, A. M., DeLisa, M. P., & Putnam, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805532107 · Cited by 302
Shi, G.-N., Zhang, C.-N., Xu, R., Niu, J.-F., Song, H.-J., Zhang, X.-Y., Wang, W.-W., Wang, Y.-M., Li, C., Wei, X.-Q., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.047 · Cited by 299
Song, X., Xu, J., Liang, C., Chao, Y., Jin, Q., Wang, C., Chen, M., & Liu, Z. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02720 · Cited by 298
PD‐1 Blockade Cellular Vesicles for Cancer Immunotherapy
Zhang, X., Wang, C., Wang, J., Hu, Q., Langworthy, B., Ye, Y., Sun, W., Lin, J., Wang, T., Fine, J., et al. (2018) · Advanced Materials · doi:10.1002/adma.201707112 · Cited by 290
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
Wang, C., Ye, Y., Hu, Q., Bellotti, A., & Gu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201606036 · Cited by 286
Xu, Z., Wang, Y., Zhang, L., & Huang, L. (2014) · ACS Nano · doi:10.1021/nn500216y · Cited by 284
Chiang, C.-S., Lin, Y.-J., Lee, R., Lai, Y.-H., Cheng, H.-W., Hsieh, C.-H., Shyu, W.-C., & Chen, S.-Y. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0146-7 · Cited by 283
Nanomaterials for cancer immunotherapy
Song, W., Musetti, S. N., & Huang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.017 · Cited by 281
Self-citationNegative regulation of Toll-like receptor 4 signaling by IL-10–dependent microRNA-146b
Curtale, G., Mirolo, M., Renzi, T. A., Rossato, M., Bazzoni, F., & Locati, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219852110 · Cited by 277
Rosalia, R. A., Cruz, L. J., van Duikeren, S., Tromp, A. T., Silva, A. L., Jiskoot, W., de Gruijl, T., Löwik, C., Oostendorp, J., van der Burg, S. H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.053 · Cited by 269
Meng, L., Cheng, Y., Tong, X., Gan, S., Ding, Y., Zhang, Y., Wang, C., Xu, L., Zhu, Y., Wu, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b03590 · Cited by 268
Nanomedicine in cancer therapy: Innovative trends and prospects
Blanco, E., Hsiao, A., Mann, A. P., Landry, M. G., Meric‐Bernstam, F., & Ferrari, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01941.x · Cited by 265
Stimulation of anti-tumor immunity by photodynamic therapy
Mroz, P., Hashmi, J. T., Huang, Y.-Y., Lange, N., & Hamblin, M. R. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.81 · Cited by 261
Cationic liposomes as vaccine adjuvants
Christensen, D., Korsholm, K. S., Andersen, P., & Agger, E. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.17 · Cited by 259
Immunomodulatory spherical nucleic acids
Radovic-Moreno, A. F., Chernyak, N., Mader, C. C., Nallagatla, S., Kang, R. S., Hao, L., Walker, D. A., Halo, T. L., Merkel, T. J., Rische, C. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502850112 · Cited by 259
Han, J., Kim, Y. S., Lim, M.-Y., Kim, H. Y., Kong, S., Kang, M., Choo, Y. W., Jun, J. H., Ryu, S., Jeong, H.-Y., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b09107 · Cited by 258
Targeting T cell metabolism for therapy
O'Sullivan, D., & Pearce, E. L. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.004 · Cited by 254
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Collins, K. A., Snaith, R., Cottingham, M. G., Gilbert, S. C., & Hill, A. V. S. (2017) · Scientific Reports · doi:10.1038/srep46621 · Cited by 253
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
Sunshine, J. C., Perica, K., Schneck, J. P., & Green, J. J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.050 · Cited by 244
The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects
Zamanian-Daryoush, M., Lindner, D., Tallant, T. C., Wang, Z., Buffa, J., Klipfell, E., Parker, Y., Hatala, D., Parsons-Wingerter, P., Rayman, P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468967 · Cited by 244
van Dissel, J. T., Joosten, S. A., Hoff, S. T., Soonawala, D., Prins, C., Hokey, D. A., O’Dee, D. M., Graves, A., Thierry-Carstensen, B., Andreasen, L. V., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.036 · Cited by 243
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape
Endoh, T., & Ohtsuki, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.005 · Cited by 242
Therapeutic Nanoparticles in Clinics and Under Clinical Evaluation
Schütz, C. A., Juillerat-Jeanneret, L., Mueller, H., Lynch, I., & Riediker, M. (2013) · Nanomedicine · doi:10.2217/nnm.13.8 · Cited by 242
A carbon nanotube–polymer composite for T-cell therapy
Fadel, T. R., Sharp, F. A., Vudattu, N., Ragheb, R., Garyu, J., Kim, D., Hong, E., Li, N., Haller, G. L., Pfefferle, L. D., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.154 · Cited by 240
Moghimi, S. M., & Patel, H. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00131-2 · Cited by 240
Organelle-specific initiation of cell death
Galluzzi, L., Bravo-San Pedro, J. M., & Kroemer, G. (2014) · Nature Cell Biology · doi:10.1038/ncb3005 · Cited by 239
Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
Musetti, S., & Huang, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b05893 · Cited by 239
Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in Neuroblastoma
Sweeney, E. E., Cano‐Mejia, J., & Fernandes, R. (2018) · Small · doi:10.1002/smll.201800678 · Cited by 238
Platelet ITAM signaling is critical for vascular integrity in inflammation
Boulaftali, Y., Hess, P. R., Getz, T. M., Cholka, A., Stolla, M., Mackman, N., Owens, A. P., Ware, J., Kahn, M. L., & Bergmeier, W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65154 · Cited by 237
Perica, K., Tu, A., Richter, A., Bieler, J. G., Edidin, M., & Schneck, J. P. (2014) · ACS Nano · doi:10.1021/nn405520d · Cited by 236
Min, J., Choi, K. Y., Dreaden, E. C., Padera, R. F., Braatz, R. D., Spector, M., & Hammond, P. T. (2016) · ACS Nano · doi:10.1021/acsnano.6b00087 · Cited by 232
Kwon, D., Cha, B. G., Cho, Y., Min, J., Park, E.-B., Kang, S.-J., & Kim, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04130 · Cited by 224
Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
Li, S.-Y., Liu, Y., Xu, C.-F., Shen, S., Sun, R., Du, X.-J., Xia, J.-X., Zhu, Y.-H., & Wang, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.044 · Cited by 222
Scott, E. A., Stano, A., Gillard, M., Maio-Liu, A. C., Swartz, M. A., & Hubbell, J. A. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.060 · Cited by 221
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
Fan, Y., Kuai, R., Xu, Y., Ochyl, L. J., Irvine, D. J., & Moon, J. J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03218 · Cited by 220
Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy
Harrigana, P. R., Whaley, M., & Montaner, J. S. G. (1999) · AIDS · doi:10.1097/00002030-199905280-00001 · Cited by 219
New opportunities for nanoparticles in cancer immunotherapy
Park, W., Heo, Y.-J., & Han, D. K. (2018) · Biomaterials Research · doi:10.1186/s40824-018-0133-y · Cited by 216
Zhang, Y., Wang, F., Li, M., Yu, Z., Qi, R., Ding, J., Zhang, Z., & Chen, X. (2018) · Advanced Science · doi:10.1002/advs.201700821 · Cited by 215
Self-citationSato, K., Sato, N., Xu, B., Nakamura, Y., Nagaya, T., Choyke, P. L., Hasegawa, Y., & Kobayashi, H. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6843 · Cited by 213
Zhang, Q., Wei, W., Wang, P., Zuo, L., Li, F., Xu, J., Xi, X., Gao, X., Ma, G., & Xie, H.-Y. (2017) · ACS Nano · doi:10.1021/acsnano.7b04955 · Cited by 210
Kim, H., Niu, L., Larson, P., Kucaba, T. A., Murphy, K. A., James, B. R., Ferguson, D. M., Griffith, T. S., & Panyam, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.034 · Cited by 210
Miller, S. D., Wetzig, R. P., & Claman, H. N. (1979) · The Journal of experimental medicine · doi:10.1084/jem.149.3.758 · Cited by 209
Fuchs, A.-K., Syrovets, T., Haas, K. A., Loos, C., Musyanovych, A., Mailänder, V., Landfester, K., & Simmet, T. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.064 · Cited by 209
Su, F., Kozak, K. R., Imaizumi, S., Gao, F., Amneus, M. W., Grijalva, V., Ng, C., Wagner, A., Hough, G., Farias-Eisner, G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009010107 · Cited by 206
Dreno, B., Thompson, J. F., Smithers, B. M., Santinami, M., Jouary, T., Gutzmer, R., Levchenko, E., Rutkowski, P., Grob, J.-J., Korovin, S., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30254-7 · Cited by 205
Shi, C., Liu, T., Guo, Z., Zhuang, R., Zhang, X., & Chen, X. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03568 · Cited by 202
Self-citationKwon, Y. J., James, E., Shastri, N., & Fréchet, J. M. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509541102 · Cited by 201
Goldinger, S. M., Dummer, R., Baumgaertner, P., Mihic‐Probst, D., Schwarz, K., Hammann‐Haenni, A., Willers, J., Geldhof, C., Prior, J. O., Kündig, T. M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142361 · Cited by 201
T‐Cell‐Mimicking Nanoparticles Can Neutralize HIV Infectivity
Wei, X., Zhang, G., Ran, D., Krishnan, N., Fang, R. H., Gao, W., Spector, S. A., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201802233 · Cited by 201
Ou, W., Thapa, R. K., Jiang, L., Soe, Z. C., Gautam, M., Chang, J.-H., Jeong, J.-H., Ku, S. K., Choi, H.-G., Yong, C. S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.018 · Cited by 200
Butts, C., Maksymiuk, A., Goss, G., Soulières, D., Marshall, E., Cormier, Y., Ellis, P. M., Price, A., Sawhney, R., Beier, F., et al. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1003-3 · Cited by 199
Kong, M., Tang, J., Qiao, Q., Wu, T., Qi, Y., Tan, S., Gao, X., & Zhang, Z. (2017) · Theranostics · doi:10.7150/thno.19987 · Cited by 197
Beldman, T. J., Senders, M. L., Alaarg, A., Pérez-Medina, C., Tang, J., Zhao, Y., Fay, F., Deichmöller, J., Born, B., Desclos, E., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b01385 · Cited by 196
A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy
Mi, Y., Smith, C. C., Yang, F., Qi, Y., Roche, K. C., Serody, J. S., Vincent, B. G., & Wang, A. Z. (2018) · Advanced Materials · doi:10.1002/adma.201706098 · Cited by 196
Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses
Deng, L., Mohan, T., Chang, T. Z., Gonzalez, G. X., Wang, Y., Kwon, Y.-M., Kang, S.-M., Compans, R. W., Champion, J. A., & Wang, B.-Z. (2018) · Nature Communications · doi:10.1038/s41467-017-02725-4 · Cited by 189
Gros, A., Syvannarath, V., Lamrani, L., Ollivier, V., Loyau, S., Goerge, T., Nieswandt, B., Jandrot-Perrus, M., & Ho-Tin-Noé, B. (2015) · Blood · doi:10.1182/blood-2014-12-617159 · Cited by 188
Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis
Heo, R., You, D. G., Um, W., Choi, K. Y., Jeon, S., Park, J.-S., Choi, Y., Kwon, S., Kim, K., Kwon, I. C., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.044 · Cited by 188
Steenblock, E. R., & Fahmy, T. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.11 · Cited by 187
Improving Vaccine and Immunotherapy Design Using Biomaterials
Bookstaver, M. L., Tsai, S. J., Bromberg, J. S., & Jewell, C. M. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.10.002 · Cited by 183
Luo, L., Zhu, C., Yin, H., Jiang, M., Zhang, J., Qin, B., Luo, Z., Yuan, X., Yang, J., Li, W., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00204 · Cited by 177
Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
Gordon, J. R., Ma, Y., Churchman, L., Gordon, S. A., & Dawicki, W. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00007 · Cited by 176
Teo, P. Y., Yang, C., Whilding, L. M., Parente‐Pereira, A. C., Maher, J., George, A. J. T., Hedrick, J. L., Yang, Y. Y., & Ghaem‐Maghami, S. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500089 · Cited by 172
Zhang, C., Shi, G., Zhang, J., Song, H., Niu, J., Shi, S., Huang, P., Wang, Y., Wang, W., Li, C., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.020 · Cited by 172
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
Yuan, H., Jiang, W., von Roemeling, C. A., Qie, Y., Liu, X., Chen, Y., Wang, Y., Wharen, R. E., Yun, K., Bu, G., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.69 · Cited by 172
Recent progress in polymer-based platinum drug delivery systems
Xiao, H., Yan, L., Dempsey, E. M., Song, W., Qi, R., Li, W., Huang, Y., Jing, X., Zhou, D., Ding, J., et al. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2018.07.004 · Cited by 172
Self-citationLi, S., Zhang, Y., Wang, J., Zhao, Y., Ji, T., Zhao, X., Ding, Y., Zhao, X., Zhao, R., Li, F., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0115-8 · Cited by 171
Tian, Y., Wang, H., Liu, Y., Mao, L., Chen, W., Zhu, Z., Liu, W., Zheng, W., Zhao, Y., Kong, D., et al. (2014) · Nano Letters · doi:10.1021/nl404560v · Cited by 170
Peptide–MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices
Singha, S., Shao, K., Yang, Y., Clemente-Casares, X., Solé, P., Clemente, A., Blanco, J., Dai, Q., Song, F., Liu, S. W., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.56 · Cited by 166
Functional muscle recovery with nanoparticle-directed M2 macrophage polarization in mice
Raimondo, T. M., & Mooney, D. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806908115 · Cited by 166
The Sociomicrobiology of Antivirulence Drug Resistance: a Proof of Concept
Mellbye, B., & Schuster, M. (2011) · mBio · doi:10.1128/mbio.00131-11 · Cited by 164
Chahal, J. S., Fang, T., Woodham, A. W., Khan, O. F., Ling, J., Anderson, D. G., & Ploegh, H. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-00193-w · Cited by 161
Dysregulation of Macrophage Activation Profiles by Engineered Nanoparticles
Kodali, V., Littke, M. H., Tilton, S. C., Teeguarden, J. G., Shi, L., Frevert, C. W., Wang, W., Pounds, J. G., & Thrall, B. D. (2013) · ACS Nano · doi:10.1021/nn402145t · Cited by 159
Intracellular Antibody Neutralizes Listeria Growth
Edelson, B. T., & Unanue, E. R. (2001) · Immunity · doi:10.1016/s1074-7613(01)00139-x · Cited by 159
Harnessing Nanoparticles for Immunomodulation and Vaccines
Gomes, A., Mohsen, M., & Bachmann, M. (2017) · Vaccines · doi:10.3390/vaccines5010006 · Cited by 158
Why certain dyes are useful for localizing the sentinel lymph node.
Tsopelas, C., & Sutton, R. (2002) · PubMed · Cited by 157
Oyen, D., Torres, J. L., Wille-Reece, U., Ockenhouse, C. F., Emerling, D. E., Glanville, J., Volkmuth, W., Flores-García, Y., Zavala, F. P., Ward, A. B., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715812114 · Cited by 156
Immunomodulating Nanomedicine for Cancer Therapy
Liu, Z., Jiang, W., Nam, J., Moon, J. J., & Kim, B. Y. S. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02340 · Cited by 154
Ding, J., Chen, J., Li, D., Xiao, C., Zhang, J., He, C., Zhuang, X., & Chen, X. (2012) · Journal of Materials Chemistry B · doi:10.1039/c2tb00063f · Cited by 152
Self-citationSasso, M. S., Lollo, G., Pitorre, M., Solito, S., Pinton, L., Valpione, S., Bastiat, G., Mandruzzato, S., Bronte, V., Marigo, I., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.010 · Cited by 150
Kim, S., Noh, Y., Kang, T. H., Kim, J., Kim, S., Um, S. H., Oh, D., Park, Y., & Lim, Y. T. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.034 · Cited by 149
Immunological basis for enhanced immunity of nanoparticle vaccines
Kelly, H. G., Kent, S. J., & Wheatley, A. K. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1578216 · Cited by 149
Nanovaccines and their mode of action
Zaman, M., Good, M. F., & Tóth, I. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.014 · Cited by 148
Engineering nanoparticle strategies for effective cancer immunotherapy
Yoon, H. Y., Selvan, S. T., Yang, Y., Kim, M. J., Yi, D. K., Kwon, I. C., & Kim, K. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.036 · Cited by 148
Cited by
Chang, M., Wang, M., Wang, M., Shu, M., Ding, B., Li, C., Pang, M., Cui, S., Hou, Z., & Lin, J. (2019) · Advanced Materials · doi:10.1002/adma.201905271 · Cited by 484
Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
Zhang, M., Hu, W., Cai, C., Wu, Y., Li, J., & Dong, S. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100223 · Cited by 394
Biocompatibility of nanomaterials and their immunological properties
Kyriakides, T. R., Raj, A., Tseng, T. H., Xiao, H., Nguyen, R., Mohammed, F. S., Halder, S., Xu, M., Wu, M. J., Bao, S., et al. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe5fa · Cited by 389
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Zhang, J., Lin, Y., Lin, Z., Wei, Q., Qian, J., Ruan, R., Jiang, X., Hou, L., Song, J., Ding, J., et al. (2022) · Advanced Science · doi:10.1002/advs.202103444 · Cited by 292
Self-citationSong, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Metadata
- Authors
- Feng, X., Xu, W., Li, Z., Song, W., Ding, J., & Chen, X.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2019-06-21
- Volume
- 6
- Issue
- 17
- Pages
- 1900101-1900101
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W4211179700
- Cited by
- 363
- References
- 331
- FWCI
- 16.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.